Reuters logo
BRIEF-Ascendis Pharma reports publication of comprehensive results from phase 2 trial of transcon growth hormone
February 16, 2017 / 9:42 PM / 8 months ago

BRIEF-Ascendis Pharma reports publication of comprehensive results from phase 2 trial of transcon growth hormone

Feb 16 (Reuters) - Ascendis Pharma A/S :

* Ascendis Pharma A/S announces publication of comprehensive results from randomized, active-controlled phase 2 trial of once-weekly transcon growth hormone in pediatric patients Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below